000 | 02800nam a22004095i 4500 | ||
---|---|---|---|
001 | 295387 | ||
003 | MX-SnUAN | ||
005 | 20160429155225.0 | ||
007 | cr nn 008mamaa | ||
008 | 150903s2007 gw | o |||| 0|eng d | ||
020 |
_a9783540313397 _99783540313397 |
||
024 | 7 |
_a10.1007/9783540313397 _2doi |
|
035 | _avtls000347653 | ||
039 | 9 |
_a201509030919 _bVLOAD _c201405050339 _dVLOAD _y201402070936 _zstaff |
|
040 |
_aMX-SnUAN _bspa _cMX-SnUAN _erda |
||
050 | 4 | _aRC261-271 | |
100 | 1 |
_aBringmann, P. _eeditor. _9329773 |
|
245 | 1 | 0 |
_aSystems Biology : _bApplications and Perspectives / _cedited by P. Bringmann, E. C. Butcher, G. Parry, B. Weiss. |
264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2007. |
|
300 |
_axiii, 172 páginas 40 ilustraciones _brecurso en línea. |
||
336 |
_atexto _btxt _2rdacontent |
||
337 |
_acomputadora _bc _2rdamedia |
||
338 |
_arecurso en línea _bcr _2rdacarrier |
||
347 |
_aarchivo de texto _bPDF _2rda |
||
490 | 0 |
_aErnst Schering Research Foundation Workshop, _x0947-6075 ; _v61 |
|
500 | _aSpringer eBooks | ||
505 | 0 | _aRNAi Applications in Target Validation -- Does the Serum Peptidome Reveal Hemostatic Dysregulation? -- Systems Biology: New Paradigms for Cell Biology and Drug Design -- The Theory of Biological Robustness and Its Implication in Cancer -- Network Genomics -- A Plea for More Theory in Molecular Biology -- Applying a Causal Framework to System Modeling -- Can Cell Systems Biology Rescue Drug Discovery?. | |
520 | _aThis volume features contributions from participants of an ESRF Workshop on "Systems Biology" held in Berkeley, USA, in November 2005. Significant progress has been made in developing technologies that enable systems interrogations at a molecular level. Overwhelming data sets are generated ever faster, providing enormous detail. In order to be useful, however, all these data must be appropriately integrated, analyzed in the context of all other information available and eventually modelled, enabling predictions for therapeutic interventions. Recent successes and challenges of applying systems level measurements to the different steps of drug discovery and development in the pharmaceutical industry are summarized. | ||
590 | _aPara consulta fuera de la UANL se requiere clave de acceso remoto. | ||
700 | 1 |
_aButcher, E. C. _eeditor. _9329774 |
|
700 | 1 |
_aParry, G. _eeditor. _9329775 |
|
700 | 1 |
_aWeiss, B. _eeditor. _9329776 |
|
710 | 2 |
_aSpringerLink (Servicio en línea) _9299170 |
|
776 | 0 | 8 |
_iEdición impresa: _z9783540313380 |
856 | 4 | 0 |
_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-540-31339-7 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL) |
942 | _c14 | ||
999 |
_c295387 _d295387 |